ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 15 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,998 | -38.3% | 24,046 | +3.0% | 0.00% | – |
| Q1 2023 | $8,094 | +304.7% | 23,346 | +180.6% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 8,321 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -72.7% | 8,321 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -56.0% | 8,321 | 0.0% | 0.00% | – |
| Q1 2022 | $25,000 | +13.6% | 8,321 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | -37.1% | 8,321 | 0.0% | 0.00% | – |
| Q3 2021 | $35,000 | +66.7% | 8,321 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | +5.0% | 8,321 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | +122.2% | 8,321 | +58.3% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 5,258 | -16.2% | 0.00% | – |
| Q3 2020 | $9,000 | 0.0% | 6,274 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | -10.0% | 6,274 | -20.5% | 0.00% | – |
| Q1 2020 | $10,000 | – | 7,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Manchester Capital Management LLC | 1,202,452 | $250,351 | 0.03% |
| COMMONWEALTH EQUITY SERVICES, LLC | 36,461 | $8 | 0.00% |
| Creative Planning | 10,000 | $2,082 | 0.00% |
| ROYAL BANK OF CANADA | 964 | $0 | 0.00% |
| VANGUARD GROUP INC | 203,358 | $42,339 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 17,623 | $3,669 | 0.00% |
| OSAIC HOLDINGS, INC. | 24,046 | $4,998 | 0.00% |
| WELLS FARGO & COMPANY/MN | 187 | $39 | 0.00% |
| NORTHERN TRUST CORP | 29,705 | $6,185 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |